{
  "ticker": "THL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976193",
  "id": "02976193",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250804",
  "time": "0730",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250804/pdf/06mgz0nnm15d95.pdf",
  "summary": "- **Response to NBIO (Non-Binding Indicative Offer)**:  \n  - Board rejects $2.30/share offer from BGH Capital and Trouchet family consortium as undervalued.  \n  - Believes fair value exceeds $3.00/share, citing cyclical lows and strategic initiatives.  \n  - Remains open to improved offers.  \n\n- **FY25 Financial Guidance**:  \n  - Underlying NPAT expected at lower end of analyst range ($27.0M\u2013$34.4M), per 4 July 2025 guidance.  \n  - Statutory NPAT likely a loss due to potential impairments:  \n    - Up to $36M (pre-tax) in USA goodwill impairment ($27M post-tax).  \n    - Up to $21M in deferred tax write-offs (USA/UK).  \n\n*(Omitted: Operational details, director names, and jurisdictional footnotes as non-material.)*",
  "usage": {
    "prompt_tokens": 1437,
    "completion_tokens": 190,
    "total_tokens": 1627,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-08-03T21:55:17.631175"
}